Project Details
| Status | Active |
|---|---|
| Effective start/end date | 5/12/16 → 5/12/24 |
Funding
- ICON Clinical Research, LLC (Prot #R475-PN-1523)
- Regeneron Pharmaceuticals, Inc. (Prot #R475-PN-1523)
Prot #R475-PN-1523: A Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients with Pain Due to Osteoarthritis of the Knee or Hip
- Schnitzer, Thomas J (PD/PI)
Project: Research project